SCHEMBL8056152

SCHEMBL8056152

COc1ccc2c(c1)CC[C@@H]1[C@@H]2CC[C@@]2(C)C13C=C[C@]2(C(C)=O)CC3

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 5/20 0.51
SMN1; SMN2 Q16637 3/20 0.51
MAPT P10636 2/20 0.51
HSD17B1 P14061 2/20 0.51
RECQL P46063 1/20 0.51
ESR1 P03372 4/20 0.50
HSD17B10 Q99714 1/20 0.48
CYP3A4 P08684 3/20 0.45
PGR P06401 2/20 0.45
SLC6A3 Q01959 2/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2C19 P33261 1/20 0.45
HIF1A Q16665 1/20 0.45
NR3C1 P04150 1/20 0.45
CNR1 P21554 1/20 0.45
SLC6A2 P23975 1/20 0.45
SLC6A4 P31645 1/20 0.45
ADORA3 P0DMS8 1/20 0.43
AR P10275 1/20 0.43
CHRM1 P11229 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8055169 1.00 LMNA (0.51) LMNASMN1; SMN2MAPTHSD17B1RECQL
SCHEMBL8056168 0.89 LMNA (0.48) LMNASMN1; SMN2MAPTHSD17B1RECQL
SCHEMBL9628187 0.84 ESR1 (0.51) LMNASMN1; SMN2MAPTHSD17B1RECQL
SCHEMBL9725104 0.84 ESR1 (0.51) LMNASMN1; SMN2MAPTHSD17B1RECQL
SCHEMBL9628599 0.83 LMNA (0.52) LMNASMN1; SMN2MAPTHSD17B1RECQL
SCHEMBL15979563 0.81 LMNA (0.52) LMNASMN1; SMN2MAPTHSD17B1RECQL
SCHEMBL8096819 0.79 LMNA (0.46) LMNASMN1; SMN2MAPTHSD17B1RECQL
SCHEMBL8059625 0.79 LMNA (0.48) LMNASMN1; SMN2MAPTHSD17B1RECQL
SCHEMBL10644810 0.79 LMNA (0.46) LMNASMN1; SMN2MAPTHSD17B1RECQL
SCHEMBL8056155 0.78 LMNA (0.53) LMNASMN1; SMN2MAPTHSD17B1RECQL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6147065-A 14-α, 17-α-C2 bridged norprogesterone derivatives SCHERING AKTIENGESELLSCHAFT (DE) 2000-11-14 US disclosed
EP-0799238-B1 14ALPHA,17ALPHA-C2-BRIDGED 19-NOR-PROGESTERONE DERIVATIVES SCHERING AG (DE) 2000-05-24 EP disclosed
US-5973172-A 14-α,17-α-C2 -bridged norprogesterone derivatives SCHERING AKITENGESELLSCHAFT (DE) 1999-10-26 US disclosed
US-5827842-A 14α, 17α-C2 -bridged norprogesterone derivatives SCHERING AKTIENGESELLSCHAFT (DE) 1998-10-27 US disclosed